M-MDSC in vitro generation from mouse bone marrow with IL-3 reveals high expression and functional activity of arginase 1

Front Immunol. 2023 May 19:14:1130600. doi: 10.3389/fimmu.2023.1130600. eCollection 2023.

Abstract

Myeloid-derived suppressor cells (MDSC) represent major regulators of immune responses, which can control T cells via their inducible nitric oxide synthase (iNOS)- and arginase 1 (Arg1)-mediated effector functions. While GM-CSF is well documented to promote MDSC development, little is known about this potential of IL-3, an established growth factor for mast cells. Here, we show that IL-3, similar to GM-CSF, generates monocytic MDSC (M-MDSC) from murine bone marrow (BM) cells after 3 days of in vitro culture. At this time point, predominantly CD11b+ CD49a+ monocytic and CD11b+ CD49a- FcεR I- neutrophilic cells were detectable, while CD11blow/neg FcεR I+ mast cells accumulated only after extended culture periods. Both growth factors were equivalent in generating M-MDSC with respect to phenotype, cell yield and typical surface markers. However, IL-3 generated M-MDSC produced less TNF, IL-1β and IL-10 after activation with LPS + IFN-γ but showed higher Arg1 expression compared to GM-CSF generated M-MDSC. Arg1 was further induced together with iNOS after MDSC activation. Accordingly, an increased Arg1-dependent suppressor activity by the IL-3 generated M-MDSC was observed using respective iNOS and Arg1 inhibitors. Together, these data indicate that M-MDSC can be generated in vitro by IL-3, similar to GM-CSF, but with increased Arg1 expression and Arg1-mediated suppression capacity. This protocol now allows further in vitro studies on the role of IL-3 for MDSC biology.

Keywords: GM-CSF; IL-3; bone marrow; in vitro culture; myeloid-derived suppressor cells (MDSC); protocol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / metabolism
  • Bone Marrow / metabolism
  • Granulocyte-Macrophage Colony-Stimulating Factor* / pharmacology
  • Integrin alpha1
  • Interleukin-3 / pharmacology
  • Mice
  • Myeloid-Derived Suppressor Cells*

Substances

  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Interleukin-3
  • Arginase
  • Integrin alpha1

Grants and funding

This work was supported by funding through the German Research Foundation (DFG LU851/18-1) and the The Interdisciplinary Center for Clinical Research (IZKF A-408) of the Medical Faculty of the University of Würzburg. This publication was supported by the Open Access Publication Fund of the University of Würzburg.